We are very pleased to announce that The Netherlands Organization for Scientific Research (NWO) has granted the Take-Off Phase II loan (€250.000) for the further development of our lead compound, Microlyse.
BIMINI Biotech, an innovative therapeutics startup that develops new cancer drugs, has secured an investment of €200,000 from proof-of-concept fund UNIIQ to further develop its technology.
TargED (formerly IOVA) closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug
TargED Biopharmaceuticals, a biotech spin-
“With its commitment to enhancing treatment options for the most urgent medical needs, GlycoCheck and Microvascular Health Solutions is moving the needle in microvascular health and ensuring quality care for all,” reported MedTech Outlook
Spin-off van de TU Delft BIOND Solutions (Bi/ond) ontwikkelde een microchip om menselijke cellen en weefsels op te kweken en te voorzien van zuurstof en voedingsstoffen.
Sirius Medical is proud to announce the first clinical results and global commercial implants of the Sirius Pintuition system.
The first clinical safety and performance study shows that Sirius Pintuition System is safe and performs as intended for breast cance
Merely a couple of weeks after the Finals of the Venture Challenge summer Edition, six new teams started their Venture Challenge adventure in the Fall 2020 edition with their first bootcamp at Pivot Park.